StreetAlpha
Emergent BioSolutions Inc. · SEC Form 4

EBS Insider Trading

From SEC Form 420 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Emergent BioSolutions Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $986K sold.

← EBS stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$986K9 sales · 6 insiders
Net−$986Kbought minus sold
Planned sales73%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $263KDecJanFebMar2026-04: sold $162KApr2026-05: sold $390KMayJun2026-07: sold $25KJulAugSep2026-10: sold $146KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when EBS insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an EBS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every EBS insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 7, 2026Donald W DeGolyerDirectorSale plan17,800$7.09$126K111,921Oct 7Form 4
Oct 1, 2026Paul Anthony WilliamsSVP, Products BusinessSale plan3,000$6.53$20K156,098Oct 5Form 4
Jul 1, 2026Paul Anthony WilliamsSVP, Products BusinessSale plan3,000$8.40$25K159,098Jul 2Form 4
May 1, 2026Sujata Tyagi DayalDirectorSale plan13,761$8.40$116K100,563May 4Form 4
May 1, 2026Donald W DeGolyerDirectorSale plan15,481$8.40$130K129,721May 4Form 4
May 1, 2026Kathryn C ZoonDirectorSale plan17,202$8.40$144K79,941May 4Form 4
Apr 30, 2026Keith KatkinDirectorSale plan15,481$8.28$128K96,294May 4Form 4
Apr 1, 2026Paul Anthony WilliamsSVP, Products BusinessSale plan4,000$8.44$34K62,681Apr 3Form 4
Dec 5, 2025Ronald RichardDirectorSale21,984$11.97$263K98,417Dec 9Form 4
Nov 10, 2025Donald W DeGolyerDirectorSale17,801$10.54$188K119,858Nov 12Form 4
Nov 7, 2025Sujata Tyagi DayalDirectorSale8,552$10.00$86K88,980Nov 10Form 4
Oct 7, 2025Coleen GlessnerEVP, Quality & Ethics, and CPLSale30,608$10.00$306K144,319Oct 16Form 4
Aug 15, 2025Kathryn C ZoonDirectorSale plan7,086$8.87$63K71,799Aug 18Form 4
Aug 12, 2025Donald W DeGolyerDirectorSale7,844$8.65$68K137,659Aug 13Form 4
May 23, 2025Keith KatkinDirectorSale plan7,844$6.30$49K86,431May 28Form 4
🔒 5 more trades. Create a free account or sign in to see them all.

EBS insider trading FAQ

Are EBS insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of EBS on the open market in 0 trades, and 6 sold $986K in 9 trades, 73% of that under pre-arranged trading plans.

When did an EBS insider last buy shares?

Joseph C Papa (President and CEO) bought 60,000 shares for $350K on May 13, 2025, reported on May 15, 2025.

When did an EBS insider last sell shares?

Donald W DeGolyer (Director) sold 17,800 shares for $126K on Oct 7, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice